SIMILAR PATTERNS OF AMINO ACIDS FOR 3WEN_A_ACRA1001
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dot | DUCK OVOTRANSFERRIN (Anasplatyrhynchos) |
PF00405(Transferrin) | 5 | ALA A 94ILE A 138TRP A 125PHE A 207HIS A 116 | None | 1.25A | 3wenA-1dotA:undetectable | 3wenA-1dotA:20.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gny | XYLANASE 10C (Cellvibriojaponicus) |
PF03426(CBM_15) | 5 | ALA A 240ASN A 92ASP A 205ASP A 207ASP A 146 | None | 1.24A | 3wenA-1gnyA:undetectable | 3wenA-1gnyA:9.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gvc | OVOTRANSFERRIN (Anasplatyrhynchos) |
PF00405(Transferrin) | 5 | ALA A 97ILE A 141TRP A 128PHE A 210HIS A 119 | None | 1.25A | 3wenA-1gvcA:undetectable | 3wenA-1gvcA:11.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t0a | 2C-METHYL-D-ERYTHRITOL2,4-CYCLODIPHOSPHATESYNTHASE (Shewanellaoneidensis) |
PF02542(YgbB) | 5 | ALA A 120ASP A 40ILE A 21ASP A 74ASP A 121 | None | 1.39A | 3wenA-1t0aA:undetectable | 3wenA-1t0aA:9.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t3q | QUINOLINE2-OXIDOREDUCTASELARGE SUBUNIT (Pseudomonasputida) |
PF01315(Ald_Xan_dh_C)PF02738(Ald_Xan_dh_C2) | 5 | ASP B 159ALA B 157ASN B 164ILE B 57ARG B 110 | SO4 B3105 ( 4.8A)NoneNoneNoneSO4 B3105 (-2.9A) | 1.42A | 3wenA-1t3qB:undetectable | 3wenA-1t3qB:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vkz | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Thermotogamaritima) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 280ALA A 347ASN A 35ILE A 398ARG A 362 | None | 1.21A | 3wenA-1vkzA:undetectable | 3wenA-1vkzA:17.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cun | PHOSPHOGLYCERATEKINASE (Pyrococcushorikoshii) |
PF00162(PGK) | 5 | ALA A 148ASN A 146ASP A 65ASP A 19HIS A 360 | NoneNoneNoneGOL A 501 (-2.6A)3PG A 503 (-4.0A) | 1.38A | 3wenA-2cunA:undetectable | 3wenA-2cunA:17.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cun | PHOSPHOGLYCERATEKINASE (Pyrococcushorikoshii) |
PF00162(PGK) | 5 | ALA A 148ASN A 146ILE A 29ASP A 19HIS A 360 | NoneNoneNoneGOL A 501 (-2.6A)3PG A 503 (-4.0A) | 1.11A | 3wenA-2cunA:undetectable | 3wenA-2cunA:17.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d3i | OVOTRANSFERRIN (Gallus gallus) |
PF00405(Transferrin) | 5 | ALA A 94ILE A 138TRP A 125PHE A 207HIS A 116 | None | 1.33A | 3wenA-2d3iA:undetectable | 3wenA-2d3iA:20.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d4y | FLAGELLARHOOK-ASSOCIATEDPROTEIN 1 (Salmonellaenterica) |
no annotation | 5 | ALA A 250ASN A 337ASP A 154ASP A 291ASP A 251 | None | 1.22A | 3wenA-2d4yA:undetectable | 3wenA-2d4yA:18.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ALA A 88ASP A 212ILE A 213TRP A 318ASP A 320MET A 321ARG A 400 | NoneNoneNoneNoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A) | 1.16A | 3wenA-2g3nA:40.7 | 3wenA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 87ALA A 90ASP A 212ILE A 213PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneNoneNoneNone | 0.96A | 3wenA-2g3nA:40.7 | 3wenA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 87ASP A 212ILE A 213TRP A 318ASP A 320MET A 321ARG A 400ASP A 416PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneNoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A)BOG A2000 (-3.0A)NoneNone | 0.31A | 3wenA-2g3nA:40.7 | 3wenA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ASP A 87ASP A 212ILE A 249MET A 321ASP A 416PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.0A)NoneNone | 1.45A | 3wenA-2g3nA:40.7 | 3wenA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 416ASP A 87ARG A 400ASP A 320HIS A 252 | BOG A2000 (-3.0A)BOG A2000 (-2.7A)BOG A2000 (-3.1A)NoneNone | 1.36A | 3wenA-2g3nA:40.7 | 3wenA-2g3nA:26.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qk4 | TRIFUNCTIONAL PURINEBIOSYNTHETIC PROTEINADENOSINE-3 (Homo sapiens) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 295ALA A 370ASN A 36ILE A 421ARG A 385 | NoneNoneNoneNoneGOL A 804 (-4.2A) | 1.23A | 3wenA-2qk4A:undetectable | 3wenA-2qk4A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 5 | ASP A 239ASN A 242ASP A 553MET A 554ARG A 649 | QPS A1050 (-2.5A)NoneQPS A1050 (-3.1A)QPS A1050 (-3.1A)QPS A1050 (-3.2A) | 1.16A | 3wenA-2x2iA:32.5 | 3wenA-2x2iA:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 10 | ASP A 239ASN A 244ASP A 412TRP A 551ASP A 553MET A 554ARG A 649ASP A 665PHE A 698HIS A 731 | QPS A1050 (-2.5A)NoneQPS A1050 (-3.2A)QPS A1050 (-4.8A)QPS A1050 (-3.1A)QPS A1050 (-3.1A)QPS A1050 (-3.2A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.72A | 3wenA-2x2iA:32.5 | 3wenA-2x2iA:24.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xr1 | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR100 KD SUBUNIT (Methanosarcinamazei) |
PF07521(RMMBL)PF07650(KH_2)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | ALA A 327ASN A 326ASP A 246ASP A 209HIS A 604 | NoneNone ZN A1639 (-2.7A)None ZN A1639 (-3.3A) | 1.32A | 3wenA-2xr1A:undetectable | 3wenA-2xr1A:22.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 470TRP A 580ASP A 582ARG A 642ASP A 659PHE A 692HIS A 740 | None | 0.51A | 3wenA-2xvgA:34.6 | 3wenA-2xvgA:25.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ybx | PHOSPHATIDYLINOSITOL-5-PHOSPHATE4-KINASE TYPE-2ALPHA (Homo sapiens) |
PF01504(PIP5K) | 5 | ASP A 211ILE A 404ASP A 235ARG A 219PHE A 397 | PHD A 359 ( 3.1A)NoneNonePO4 A1406 (-3.7A)None | 1.26A | 3wenA-2ybxA:undetectable | 3wenA-2ybxA:17.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ys6 | PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE (Geobacilluskaustophilus) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 290ALA A 361ASN A 34ILE A 412ARG A 376 | None | 1.23A | 3wenA-2ys6A:undetectable | 3wenA-2ys6A:19.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yw2 | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Aquifexaeolicus) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 290ALA A 363ASN A 34ILE A 414ARG A 378 | NoneNoneNoneNonePO4 A 645 (-3.6A) | 1.28A | 3wenA-2yw2A:undetectable | 3wenA-2yw2A:18.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3af5 | PUTATIVEUNCHARACTERIZEDPROTEIN PH1404 (Pyrococcushorikoshii) |
PF07521(RMMBL)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | ALA A 342ASN A 341ASP A 260ASP A 217HIS A 618 | NoneACY A 658 (-3.4A) ZN A 665 ( 2.9A)None ZN A 665 ( 3.3A) | 1.30A | 3wenA-3af5A:2.1 | 3wenA-3af5A:22.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | ASP A 203ASN A 207ASP A 327ILE A 328TRP A 441ASP A 443MET A 444ARG A 526ASP A 542PHE A 575HIS A 600 | GOL A3001 (-2.6A)None3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-4.9A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 ( 3.5A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.69A | 3wenA-3cttA:47.5 | 3wenA-3cttA:36.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fnb | ACYLAMINOACYLPEPTIDASE SMU_737 (Streptococcusmutans) |
PF12146(Hydrolase_4) | 5 | ASN A 63ASP A 191ASP A 171ARG A 97PHE A 114 | None | 1.18A | 3wenA-3fnbA:undetectable | 3wenA-3fnbA:17.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) |
PF00293(NUDIX) | 5 | ALA A 97ASP A 23ASP A 96PHE A 140HIS A 142 | NoneAPR A 302 (-2.9A)APR A 302 (-3.6A)APR A 302 (-3.6A)APR A 302 (-4.0A) | 1.50A | 3wenA-3gz8A:undetectable | 3wenA-3gz8A:11.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i4g | SUSD-LIKECARBOHYDRATE BINDINGPROTEIN BF1063 (Bacteroidesfragilis) |
PF07980(SusD_RagB)PF14322(SusD-like_3) | 5 | ALA A 467ASN A 80ILE A 250ARG A 336PHE A 258 | None | 1.39A | 3wenA-3i4gA:undetectable | 3wenA-3i4gA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ikf | 2-C-METHYL-D-ERYTHRITOL2,4-CYCLODIPHOSPHATESYNTHASE (Burkholderiapseudomallei) |
PF02542(YgbB) | 5 | ALA A 120ASP A 40ILE A 21ASP A 74ASP A 121 | None | 1.39A | 3wenA-3ikfA:undetectable | 3wenA-3ikfA:11.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3km2 | SUPEROXIDE DISMUTASE[CU-ZN],CHLOROPLASTIC (Solanumlycopersicum) |
PF00080(Sod_Cu) | 5 | ASP A 101ASN A 110ASP A 124ARG A 79HIS A 71 | NoneNoneNoneNone ZN A 155 (-3.2A) | 1.46A | 3wenA-3km2A:2.0 | 3wenA-3km2A:10.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A 231ASP A 355ILE A 356TRP A 470ASP A 472MET A 473ARG A 555ASP A 571PHE A 604HIS A 629 | NoneTRS A6001 (-2.9A)TRS A6001 ( 4.0A)NoneTRS A6001 (-3.2A)TRS A6001 ( 3.7A)TRS A6001 ( 4.6A)TRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.29A | 3wenA-3lppA:51.5 | 3wenA-3lppA:35.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | ASP A 231ASP A 355ILE A 392MET A 473ASP A 571PHE A 604HIS A 629 | NoneTRS A6001 (-2.9A)NoneTRS A6001 ( 3.7A)TRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 1.48A | 3wenA-3lppA:51.5 | 3wenA-3lppA:35.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mjf | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Yersinia pestis) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 293ALA A 367ASN A 34ILE A 419ARG A 383 | NoneNoneNoneNoneSO4 A 508 (-3.9A) | 1.25A | 3wenA-3mjfA:undetectable | 3wenA-3mjfA:18.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ALA A 448ASN A 431ASP A 197ILE A 234ASP A 449 | NoneNoneACR A 664 (-2.9A)NoneNone | 1.34A | 3wenA-3pocA:35.3 | 3wenA-3pocA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 73ASP A 197ILE A 198MET A 308ARG A 404ASP A 420PHE A 453HIS A 478 | NoneACR A 664 (-2.9A)ACR A 664 (-3.5A)ACR A 664 ( 3.8A)ACR A 664 (-4.0A)ACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.33A | 3wenA-3pocA:35.3 | 3wenA-3pocA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 197ILE A 198TRP A 305ASP A 420PHE A 453HIS A 478 | ACR A 664 (-2.9A)ACR A 664 (-3.5A)NoneACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.82A | 3wenA-3pocA:35.3 | 3wenA-3pocA:26.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A1157ASP A1279ILE A1280TRP A1418ASP A1420MET A1421ARG A1510ASP A1526PHE A1559HIS A1584 | ACR A 1 (-2.6A)ACR A 1 (-3.2A)ACR A 1 (-4.1A)NoneACR A 1 (-3.6A)ACR A 1 (-3.5A)ACR A 1 (-2.9A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.41A | 3wenA-3topA:44.6 | 3wenA-3topA:34.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ugk | SACCHAROPINEDEHYDROGENASE [NAD+,L-LYSINE-FORMING] (Saccharomycescerevisiae) |
PF05222(AlaDh_PNT_N) | 5 | ALA A 165ASN A 299ASP A 182ARG A 149HIS A 157 | None | 1.13A | 3wenA-3ugkA:undetectable | 3wenA-3ugkA:18.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wc3 | ENDO-1,4-BETA-GLUCANASE (Eisenia fetida) |
PF00759(Glyco_hydro_9) | 5 | ASP A 60ALA A 159ASN A 63ASP A 77ARG A 157 | None | 1.48A | 3wenA-3wc3A:undetectable | 3wenA-3wc3A:19.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 12 | ASP A 232ALA A 234ASN A 237ASP A 357ILE A 358TRP A 467ASP A 469MET A 470ARG A 552ASP A 568PHE A 601HIS A 626 | ACR A1001 (-2.7A)ACR A1001 (-3.7A)ACR A1001 (-3.0A)ACR A1001 (-3.0A)ACR A1001 (-3.6A)NoneACR A1001 (-3.2A)ACR A1001 (-3.3A)ACR A1001 (-3.0A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.16A | 3wenA-3welA:65.7 | 3wenA-3welA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 9 | ASP A 232ALA A 234ASN A 237ASP A 357ILE A 396MET A 470ASP A 568PHE A 601HIS A 626 | ACR A1001 (-2.7A)ACR A1001 (-3.7A)ACR A1001 (-3.0A)ACR A1001 (-3.0A)ACR A1001 (-4.9A)ACR A1001 (-3.3A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 1.45A | 3wenA-3welA:65.7 | 3wenA-3welA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 299ILE A 341ASP A 480PHE A 513HIS A 540 | None | 1.37A | 3wenA-4b9yA:42.6 | 3wenA-4b9yA:25.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 299TRP A 410ASP A 412ARG A 463ASP A 480PHE A 513HIS A 540 | None | 0.47A | 3wenA-4b9yA:42.6 | 3wenA-4b9yA:25.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c8g | 2-C-METHYL-D-ERYTHRITOL2,4-CYCLODIPHOSPHATESYNTHASE (Burkholderiacenocepacia) |
PF02542(YgbB) | 5 | ALA A 120ASP A 40ILE A 21ASP A 74ASP A 121 | None | 1.44A | 3wenA-4c8gA:undetectable | 3wenA-4c8gA:11.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4di5 | 5-EPI-ARISTOLOCHENESYNTHASE (Nicotianatabacum) |
PF01397(Terpene_synth)PF03936(Terpene_synth_C) | 5 | ASP A 444ALA A 447ASN A 523ASP A 302ASP A 525 | DPO A 605 (-2.6A)NoneNoneNoneDPO A 605 ( 4.6A) | 1.41A | 3wenA-4di5A:undetectable | 3wenA-4di5A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rvp | SUPEROXIDE DISMUTASE (Sedum alfredii) |
PF00080(Sod_Cu) | 5 | ASP A 113ASN A 122ASP A 136ARG A 91HIS A 83 | NoneNoneNoneNone ZN A 201 (-3.1A) | 1.45A | 3wenA-4rvpA:undetectable | 3wenA-4rvpA:10.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wqe | THIOSULFATEDEHYDROGENASE (Allochromatiumvinosum) |
PF13442(Cytochrome_CBB3) | 5 | ALA A 174ASP A 34ARG A 177ASP A 173HIS A 51 | NoneNoneNoneNoneHEC A1002 (-4.9A) | 1.47A | 3wenA-4wqeA:undetectable | 3wenA-4wqeA:15.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x81 | MYCINAMICIN III3''-O-METHYLTRANSFERASE (Micromonosporagriseorubida) |
PF05711(TylF) | 5 | ASP A 244ASP A 191ILE A 220ASP A 216ARG A 61 | NoneMVI A 305 ( 2.7A)MVI A 305 ( 4.3A) MG A 304 ( 2.9A)MVI A 305 ( 4.3A) | 1.46A | 3wenA-4x81A:undetectable | 3wenA-4x81A:15.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ypv | EST8 (Parvibaculum) |
PF07859(Abhydrolase_3) | 5 | ALA A 290ASP A 158ILE A 186ASP A 42HIS A 97 | None | 1.44A | 3wenA-4ypvA:undetectable | 3wenA-4ypvA:14.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zg8 | ENDOGLUCANASE (Perinereisbrevicirris) |
PF00759(Glyco_hydro_9) | 5 | ASP A 47ALA A 144ASN A 50ASP A 64ARG A 142 | None | 1.48A | 3wenA-4zg8A:undetectable | 3wenA-4zg8A:18.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cdc | VP1, STRUCTURALPOLYPROTEIN (Israeli acuteparalysis virus) |
PF08762(CRPV_capsid) | 5 | ASP A 76ALA A 183ILE A 156ASP A 71PHE A 188 | None | 1.41A | 3wenA-5cdcA:undetectable | 3wenA-5cdcA:13.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 10 | ASP A 303ASP A 443ILE A 444TRP A 554ASP A 556MET A 557ARG A 617ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)TRS A1001 ( 4.1A)TRS A1001 (-4.9A)TRS A1001 (-3.2A)TRS A1001 (-3.5A)TRS A1001 (-4.0A)TRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.32A | 3wenA-5dkxA:45.9 | 3wenA-5dkxA:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 8 | ASP A 303ASP A 443ILE A 480MET A 557ARG A 617ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)NoneTRS A1001 (-3.5A)TRS A1001 (-4.0A)TRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 1.34A | 3wenA-5dkxA:45.9 | 3wenA-5dkxA:27.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 228ASN A 234ASP A 348ASP A 460ARG A 507PHE A 556 | None | 1.01A | 3wenA-5f7cA:32.6 | 3wenA-5f7cA:24.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ASP A 228ASP A 348ASP A 460ARG A 507ASP A 523PHE A 556HIS A 588 | None | 0.50A | 3wenA-5f7cA:32.6 | 3wenA-5f7cA:24.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 467ARG A 516ASP A 532PHE A 565HIS A 591 | CA A 805 (-2.9A) CA A 805 ( 4.6A) CA A 805 ( 4.6A)NoneNone | 0.55A | 3wenA-5f7sA:35.2 | 3wenA-5f7sA:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 305ASP A 451ILE A 452TRP A 562ASP A 564MET A 565ARG A 624ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.0A)5GF A1021 (-3.6A)5GF A1021 (-4.6A)5GF A1021 (-2.1A)5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.31A | 3wenA-5hjrA:40.9 | 3wenA-5hjrA:29.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 305ASP A 451ILE A 488MET A 565ARG A 624ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.0A)None5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 1.29A | 3wenA-5hjrA:40.9 | 3wenA-5hjrA:29.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 305TRP A 423ASP A 640PHE A 674HIS A 700 | None5GF A1021 (-3.1A)5GF A1021 (-2.6A)NoneFMT A1020 (-3.9A) | 1.44A | 3wenA-5hjrA:40.9 | 3wenA-5hjrA:29.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ip9 | DNA-DIRECTED RNAPOLYMERASE IISUBUNIT RPB2 (Saccharomycescerevisiae) |
PF00562(RNA_pol_Rpb2_6)PF04560(RNA_pol_Rpb2_7)PF04561(RNA_pol_Rpb2_2)PF04563(RNA_pol_Rpb2_1)PF04565(RNA_pol_Rpb2_3)PF04566(RNA_pol_Rpb2_4)PF04567(RNA_pol_Rpb2_5) | 5 | ALA B 793ASN B 794ILE B 204ARG B 788ASP B 790 | None | 1.44A | 3wenA-5ip9B:undetectable | 3wenA-5ip9B:21.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jd3 | LAE5 (unculturedbacterium) |
PF13472(Lipase_GDSL_2) | 5 | ALA A 150ASP A 172ASP A 178ARG A 144ASP A 153 | SO4 A 303 (-3.2A)NoneNoneNoneNone | 1.42A | 3wenA-5jd3A:undetectable | 3wenA-5jd3A:13.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASN A 319ASP A 441TRP A 551ASP A 553ARG A 613HIS A 709 | NoneEDO A1008 (-2.8A)NoneEDO A1008 (-2.7A)EDO A1008 (-4.6A)EDO A1008 (-4.0A) | 1.05A | 3wenA-5jouA:34.4 | 3wenA-5jouA:25.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 441TRP A 551ASP A 553ARG A 613ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)NoneEDO A1008 (-2.7A)EDO A1008 (-4.6A)EDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.45A | 3wenA-5jouA:34.4 | 3wenA-5jouA:25.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 7 | ASP A 282ALA A 284ASP A 404ILE A 441MET A 519ASP A 616PHE A 649 | ACR A1015 (-2.6A)ACR A1015 ( 4.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 (-3.3A)ACR A1015 (-2.7A)ACR A1015 (-4.3A) | 1.46A | 3wenA-5nn8A:47.4 | 3wenA-5nn8A:37.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 10 | ASP A 282ALA A 284ASP A 404TRP A 516ASP A 518MET A 519ARG A 600ASP A 616PHE A 649HIS A 674 | ACR A1015 (-2.6A)ACR A1015 ( 4.6A)ACR A1015 (-3.0A)NoneACR A1015 (-3.1A)ACR A1015 (-3.3A)ACR A1015 (-3.1A)ACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.33A | 3wenA-5nn8A:47.4 | 3wenA-5nn8A:37.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vev | PHOSPHORIBOSYLAMINE--GLYCINE LIGASE (Neisseriagonorrhoeae) |
PF01071(GARS_A)PF02843(GARS_C)PF02844(GARS_N) | 5 | ASP A 291ALA A 364ASN A 34ILE A 416ARG A 380 | NoneNoneNoneNoneSO4 A 511 (-3.8A) | 1.29A | 3wenA-5vevA:undetectable | 3wenA-5vevA:20.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 6 | TRP A 427ASP A 429ARG A 474ASP A 491PHE A 533HIS A 565 | None | 0.55A | 3wenA-5x7sA:18.2 | 3wenA-5x7sA:21.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 4 | ILE A 233TRP A 329TRP A 432TRP A 565 | GLC A1002 (-3.9A)ACR A1001 (-4.1A)ACR A1001 ( 4.6A)ACR A1001 (-4.8A) | 0.32A | 3wenA-3welA:65.7 | 3wenA-3welA:100.00 |